Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05028751
Status:
TERMINATED
Last Update Posted:
2024-04-22
First Post:
2021-08-25
Brief Title:
A Study to Evaluate Lanraplenib LANRA in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia AML
Sponsor:
Kronos Bio
Organization:
Kronos Bio
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-25
First Submit QC Date:
August 25 2021
Study First Post Date:
2021-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-11
Last Update Post Date:
2024-04-22
Last Update Post Date Type:
ACTUAL